<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01782404</url>
  </required_header>
  <id_info>
    <org_study_id>ABC-0008</org_study_id>
    <nct_id>NCT01782404</nct_id>
  </id_info>
  <brief_title>Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine</brief_title>
  <official_title>Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wellspect HealthCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wellspect HealthCare</source>
  <brief_summary>
    <textblock>
      This a prospective, non-controlled, open, multi-center study evaluating the reduction of&#xD;
      bacteriuria after bladder irrigation with chlorhexidine in spinal cord injured patients with&#xD;
      chronic bacteriuria practicing intermittent catheterisation (IC). Patients will be treated&#xD;
      with chlorhexidine for bladder irrigation twice daily for a maximum of 7 days.&#xD;
&#xD;
      The study hypothesis is that bladder irrigation with chlorhexidine is efficient for a short&#xD;
      term reduction of bacteriuria in patients performing intermittent catheterization (IC).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with bacteriuria &lt;10^3 CFU/ml</measure>
    <time_frame>7 days</time_frame>
    <description>Bacteriuria will be followed by daily urinary cultures, 3 hours after morning irrigation. The proportion of patients with at least one sample &lt;10^3 CFU/ml within the 7 day treatment period will be evaluated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time (number of days) to reduction of bacteriuria (&lt;10^3 CFU/ml)</measure>
    <time_frame>7 days</time_frame>
    <description>Bacteriuria will be followed by daily urinary cultures, 3 hours after morning irrigation. The number of days until reduction of bacteriuria (&lt;10^3 CFU/ml) will be evaluated. Maximum treatment period is 7 days.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Bacteriuria, Intermittent Catheterization</condition>
  <arm_group>
    <arm_group_label>Chlorhexidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chlorhexidine</intervention_name>
    <description>Bladder irrigation with chlorhexidine 0.2 mg/ml twice daily</description>
    <arm_group_label>Chlorhexidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Provision of informed consent&#xD;
&#xD;
          2. Female or male spinal cord injured subject aged 18 years and over&#xD;
&#xD;
          3. Bacteriuria of &gt;10^5 CFU/mL of &gt;1 bacterial species verified during screening visit&#xD;
&#xD;
          4. Regular users of intermittent catheterisation as primary method for bladder management&#xD;
             (defined as a normal catheterisation frequency of at least 3 times daily for at least&#xD;
             1 month)&#xD;
&#xD;
          5. Ability to retain fluid in the bladder (approx. 120 ml) for at least 10 minutes, as&#xD;
             judged by the investigator&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Signs or symptoms of symptomatic UTI that requires treatment, as judged by the&#xD;
             investigator.&#xD;
&#xD;
          2. Ongoing antibiotic treatment&#xD;
&#xD;
          3. Known anatomical pathology of the urinary tract that could compromise results, as&#xD;
             judged by investigator&#xD;
&#xD;
          4. Subject with severe catheterisation difficulties, as judged by investigator&#xD;
&#xD;
          5. Known hypersensitivity to chlorhexidine&#xD;
&#xD;
          6. Use of other instillation products&#xD;
&#xD;
          7. Pregnancy&#xD;
&#xD;
          8. Use of medications that may affect the bacterial culture in the urine and bladder&#xD;
             (e.g. methenamine hippurate)&#xD;
&#xD;
          9. Involvement in the planning and conduct of the study (applies to both Wellspect&#xD;
             HealthCare staff and staff at the study site)&#xD;
&#xD;
         10. Previous enrolment or allocation of treatment in the present study.&#xD;
&#xD;
         11. Simultaneous participation in another clinical study that may interfere with the&#xD;
             present study.&#xD;
&#xD;
         12. Severe non-compliance to protocol as judged by the investigator and/or Wellspect&#xD;
             HealthCare&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lena Rutberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spinal Cord Injury Unit, Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spinal Cord Injury Unit, Skåne University Hospital</name>
      <address>
        <city>Höör</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spinal Cord Injury Unit, Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurocentrum, Neurorehab, Norrlands Universitetssjukhus</name>
      <address>
        <city>Umeå</city>
        <zip>90185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>January 30, 2013</study_first_submitted>
  <study_first_submitted_qc>January 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2013</study_first_posted>
  <last_update_submitted>August 11, 2015</last_update_submitted>
  <last_update_submitted_qc>August 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteriuria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

